![2-Azabicyclo[3.1.0]hexane-3-carbonitrile,2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acety…](https://static.cymitquimica.com/products/IN/img/DA00I75O.png "Clique para ampliar")
2-Azabicyclo[3.1.0]hexane-3-carbonitrile,2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-
CAS: 361442-04-8
Ref. IN-DA00I75O
| 1g | Descontinuado | ||
| 10mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado |
Informação sobre produto
Nome:
2-Azabicyclo[3.1.0]hexane-3-carbonitrile,2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-
Sinónimos:
- [u'3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate', u'BMS 477118', u'BMS-477118', u'BMS477118', u'Onglyza', u'saxagliptin', u'Saxagliptin', u'Onglyza', u'361442-04-8', u'BMS-477118', u'OPC-262', u'UNII-8I7IO46IVQ', u'BMS 477118', u'Saxagliptin [INN]', u'8I7IO46IVQ', u'CHEMBL385517', u'CHEBI:71272', u'Saxagliptin (INN)', u'BMS-477118-11', u'(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile', u'(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile', u'BMS477118', u'(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile', u'Saxagliptine', u'Saxagliptin (BMS-477118,Onglyza)', u'HSDB 8199', u'OPC 262', u'NCGC00242597-01', u'Saxagliptin anhydrous', u'Saxagliptin(Onglyza)', u'DSSTox_CID_28506', u'DSSTox_RID_82778', u'DSSTox_GSID_48580', u'SCHEMBL17168', u'2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)-', u'cc-226', u'MLS006011223', u'GTPL6316', u'Saxagliptin - BMS-477118', u'DTXSID7048580', u'SCHEMBL20243458', u'BDBM11542', u'QGJUIPDUBHWZPV-SGTAVMJGSA-N', u'HMS3264P11', u'Pharmakon1600-01502500', u'Tox21_112908', u'BDBM50225074', u'NSC760407', u's1540', u'AKOS015896547', u'AC-6008', u'AN-5808', u'CCG-213084', u'DB06335', u'EX-7795', u'NSC-760407', u'NCGC00242597-02', u'SMR004702984', u'AB1008460', u'AM20090693', u'CAS-361442-04-8', u'D08996', u'Q-4418', u'AB01562984_01', u'AB01562984_02', u'I06-2477', u'BRD-A81513827-001-03-6', u'Z2235802036', u'(S)-3-Hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile TFA salt', u'(1S,6S)-2-(2-adamantan-1-yl-2-amino-acetyl)-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile', u'(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2,2,2-trifluoroacetic acid', u'(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-oxoethyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile', u'(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; Onglyza', u'(1S,3S,5S)-2-[(S)-2-amino-2-(3-hydroxy-adamantan-1-yl)-acetyl]-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile', u'(1s,3s,5s)-2-[2(s)-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile', u'(1S,3S,5S)-4-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-4-azabicyclo[3.1.0]hexane-3-carbonitrile', u'Saxagliptin HCl', u'Saxagliptin hydrate', u'Onglyza (TN)', u'Saxagliptin [USAN]', u'Kombiglyze XR (TN)', u'Saxagliptin hydrochloride', u'D0K9MY', u'UNII-9GB927LAJW', u'Saxagliptin [USAN:INN:BAN]', u'ACN-031557', u'CID11243969', u'BMS 477118-11', u'C502994', u'3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate', u'(S)-3-hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile', u'(1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile', u'945667-22-1', u'Saxagliptin, 97%, selective and reversible DPP4 inhibitor - 10MG 10mg']
- (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.1<sup>3,7</sup>]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
- (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
- (1S,3S,5S)-2-[2(S)-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.1<sup>3,7</sup>]dec-1-yl)acetyl]-, (1S,3S,5S)-
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.1<sup>3,7</sup>]dec-1-yl)acetyl]-, (1S,3S,5S)-
- Bms 477118
- Bms 477118-11
- Onglyza
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
315.4100
Fórmula:
C18H25N3O2
Pureza:
98%
Cor/forma:
Solid
InChI:
InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1
Chave InChI:
QGJUIPDUBHWZPV-SGTAVMJGSA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
